hotspot -WSS

hotspot

author：fashion 2025-09-30 01:19:41 - browse：898

Illustration of doctor with an computer text bubble for a face for a story on Chat GPT and AI – health tech coverage from STAT — Mike Reddy for STAT

Health care companies are racing to incorporate generative AI tools into their product pipelines and IT systems after the technology displayed an ability to perform many tasks faster, cheaper — and sometimes better — than humans.

But the rush to harness the power of so-called large language models, which are trained on vast troves of data, is outpacing efforts to assess their value. AI experts are still trying to understand, and explain, how and why they work better than prior systems, and what blind spots might undermine their usefulness in medicine.

It remains unclear, for example, how well these models will perform, and what privacy and ethical quandaries will arise, when they’re exposed to new types of data, such as genetic sequences, CT scans, and electronic health records. Even knowing exactly how much data must be fed into a model to achieve peak performance on a given task is still largely guesswork.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： A common UTI test for kids haunts adults as a traumatic 'nightmare'

WSS

Anthos stroke drug appears safer than common blood thinner

PEPFAR is under serious threat — and so is global health

Morphosys mixed study results for blood cancer drug

Acelyrin, a rare IPO success, stumbles in its first big test

New weight loss drugs vying to be the next Wegovy or Mounjaro

NYU radiologists take on the challenge of expensive MRI machines

focus

hotspot

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Food makers tried to stack nutrition panel with preferred experts

As demand for Covid shots wanes, Moderna seeks its next success

Ransomware attacks on hospitals: Study outlines patient impact

Medical leaders decry Supreme Court decision on affirmative action

Acelyrin, a rare IPO success, stumbles in its first big test

Medical leaders decry Supreme Court decision on affirmative action

PBM reforms clear House panel

Alkermes shareholders re

U.K. considers world's first use of meningitis vaccine to address gonorrhea

focus

Does good food count as health care? Study aims to find out

How to make the FDA’s new prescription one

Regeneron agrees to White House price limits on anti

PBM reforms clear House panel

World's first CRISPR

Anthos stroke drug appears safer than common blood thinner

hotspot

hotspot

focus

leisure time